Core Insights - Bath & Body Works (BBWI) reported quarterly earnings of $0.35 per share, missing the Zacks Consensus Estimate of $0.40 per share, and down from $0.49 per share a year ago [1][2] - The company posted revenues of $1.59 billion for the quarter, missing the Zacks Consensus Estimate by 2.02%, and down from $1.61 billion year-over-year [3] - The stock has underperformed significantly, losing about 45.7% since the beginning of the year compared to the S&P 500's gain of 12.9% [4] Earnings Performance - The earnings surprise for the quarter was -12.50%, with the company having surpassed consensus EPS estimates only two times over the last four quarters [2] - The current consensus EPS estimate for the upcoming quarter is $2.15 on revenues of $2.82 billion, and for the current fiscal year, it is $3.40 on revenues of $7.46 billion [8] Industry Context - Bath & Body Works operates within the Zacks Retail - Miscellaneous industry, which is currently ranked in the top 37% of over 250 Zacks industries [9] - The performance of Bath & Body Works may be influenced by the overall outlook for the industry, as top-ranked industries tend to outperform lower-ranked ones by a factor of more than 2 to 1 [9] Future Outlook - The company's future stock performance will largely depend on management's commentary during the earnings call and the trends in earnings estimate revisions [4][5] - The current Zacks Rank for Bath & Body Works is 3 (Hold), indicating that shares are expected to perform in line with the market in the near future [7]

Bath & Body Works® Q3 2025 Earnings & 2025 Guidance November 20, 2025 Bath & Body Works® 2 Forward-looking Statements Q3 Earnings Call Participants Daniel Heaf Chief Executive Officer Eva Boratto Chief Financial Officer Luke Long VP Strategy & Investor Relations Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995 We caution that any forward-looking statements (as such term is defined in the Private Securities Litigation Reform Act of 1995) contained in this presentation or made ...

Core Viewpoint - Bath & Body Works reported a 1% year-over-year decline in sales to $1.59 billion, falling short of analyst expectations of $1.63 billion, and adjusted earnings per share were $0.35, also below the expected $0.39 [1] Financial Performance - The company's net sales for the third quarter were $1.59 billion, a decrease of 1% compared to the previous year [1] - Adjusted earnings per share were reported at $0.35, which is lower than the anticipated $0.39 [1] Future Outlook - The company anticipates a low single-digit decline in net sales for fiscal year 2025, revising previous growth expectations of 1.5% to 2.7% [1] - Earnings per share forecast has been lowered from a range of $3.35 to $3.60 to at least $2.87 [1] Strategic Initiatives - Bath & Body Works announced a transformation plan aimed at saving $250 million in costs over the next two years [1] - The cautious attitude of American consumers towards the changing tariff policies under the Trump administration is impacting shopping budgets [1]

Core Insights - The retailer reported weaker-than-expected quarterly adjusted earnings and sales, indicating potential challenges in its operational performance [1] - The company has revised its fiscal-year outlook downward, suggesting a more cautious approach to future expectations [1] Financial Performance - The quarterly adjusted earnings fell short of market expectations, reflecting a decline in profitability [1] - Sales figures also did not meet forecasts, indicating potential issues with consumer demand or inventory management [1] Outlook - The company has slashed its fiscal-year outlook, which may impact investor confidence and stock performance moving forward [1]

Core Insights - Premarket trading is showing notable activity with significant price movements indicating potential trading opportunities before the market opens [1] Premarket Gainers - Mobile-Network Solutions (MNDR) is up 96% at $3.26 - PACS Group, Inc. (PACS) is up 44% at $24.37 - Cerence Inc. (CRNC) is up 28% at $10.16 - Magnera Corporation (MAGN) is up 26% at $10.07 - Oddity Tech Ltd. (ODD) is up 17% at $43.75 - Allot Ltd. (ALLT) is up 14% at $9.80 - Artiva Biotherapeutics, Inc. (ARTV) is up 14% at $3.88 - Kulicke and Soffa Industries, Inc. (KLIC) is up 13% at $40.22 - Fossil Group, Inc. (FOSL) is up 12% at $2.29 - NVIDIA Corporation (NVDA) is up 5% at $195.84 [3] Premarket Losers - Brera Holdings PLC (SLMT) is down 33% at $3.84 - Bath & Body Works, Inc. (BBWI) is down 14% at $18.04 - Cemtrex, Inc. (CETX) is down 11% at $3.20 - Atkore Inc. (ATKR) is down 9% at $60.00 - Gloo Holdings, Inc. (GLOO) is down 9% at $7.30 - SMX (Security Matters) Public Limited Company (SMX) is down 9% at $4.60 - Sonim Technologies, Inc. (SONM) is down 8% at $7.31 - Psyence Biomedical Ltd. (PBM) is down 7% at $2.56 - MMTec, Inc. (MTC) is down 6% at $2.00 - Ridgetech, Inc. (RDGT) is down 5% at $4.78 [4]

Core Insights - Bath & Body Works, Inc. (BBWI) reported a significant reduction in its financial outlook for the fourth quarter and full-year 2025, expecting earnings of at least $1.70 per share and a decline in net sales by high single digits from last year's $2.79 billion [1][2] - The company anticipates earnings of at least $2.83 per share for fiscal 2025, with adjusted earnings projected at least $2.87 per share, alongside a low single-digit decline in net sales from last year's $7.31 billion [2][3] Financial Performance - For the third quarter, Bath & Body Works reported a net income of $77 million ($0.37 per share), down from $106 million ($0.49 per share) in the same quarter last year [5] - Adjusted earnings for the third quarter were $0.35 per share, compared to $0.49 per share in the prior year, with net sales declining to $1.59 billion from $1.61 billion [5] Analyst Expectations - Analysts had expected earnings of $2.18 per share with a net sales growth of 1.80% to $2.84 billion for the fourth quarter, while the company’s previous guidance was for earnings between $3.28 and $3.53 per share [2][3] - The Street's expectations for the full year were earnings of $3.42 per share on a net sales growth of 2.02% to $7.45 billion [3] Strategic Initiatives - The company announced a comprehensive transformation plan called the Consumer First Formula, focusing on four key areas: innovative product creation, brand revitalization, marketplace competitiveness, and operational efficiency [6] - Bath & Body Works aims to achieve $250 million in cost savings over two years, with more than half of these savings targeted for 2026, to reinvest in revenue-generating initiatives [7] External Factors - The company's outlook for the fourth quarter and full-year 2025 includes the anticipated impact of all current tariff rates imposed by the U.S. government and other countries [4]

Financial Performance - Third quarter 2025 net sales were $1,594 million, a decrease of 1% compared to $1,610 million in the same quarter of 2024[9] - Earnings per diluted share for the third quarter of 2025 were $0.37, down from $0.49 in the prior year[9] - The company is lowering its full-year 2025 net sales guidance from a growth of 1.5% to 2.7% to a decline of low single digits compared to $7,307 million in fiscal 2024[12] - Fourth quarter 2025 net sales are expected to be down high single digits compared to $2,788 million in the fourth quarter of 2024[11] - Adjusted earnings per diluted share for the third quarter of 2025 were $0.35, compared to $0.49 last year[10] - The company expects full-year 2025 earnings per diluted share to be at least $2.83, down from $3.61 in fiscal 2024[12] - Third quarter operating income was $161 million, compared to $218 million last year[9] - Net income for Year-to-Date 2025 is $246 million, down from $345 million in 2024, representing a decrease of 28.7%[26] - Adjusted operating income for Year-to-Date 2025 is $542 million, down from $588 million in 2024, a decrease of 7.8%[34] Cost Management - The company plans to achieve $250 million in cost savings over two years, with over half identified for 2026[8] Cash Flow and Financing - The company anticipates generating free cash flow of approximately $650 million for full-year 2025[12] - The forecasted net cash provided by operating activities for 2025 is $890 million, with forecasted capital expenditures of $240 million, resulting in forecasted free cash flow of $650 million[36] - The net cash used for financing activities in Year-to-Date 2025 was $497 million, a decrease from $710 million in 2024[26] Sales Performance - Total sales for Bath & Body Works in the third quarter of 2025 were $1,594 million, a decrease of 1.0% compared to $1,610 million in 2024[28] - Direct sales in the U.S. and Canada decreased by 7.0% in the third quarter of 2025, totaling $299 million compared to $321 million in 2024[28] - International sales in the third quarter of 2025 increased by 6.1% to $73 million compared to $69 million in 2024[28] Store Operations - The company operated a total of 1,895 company-operated stores as of November 1, 2025, an increase of 39 stores from February 1, 2025[30] Tax and Income Expectations - The reported tax rate for Year-to-Date 2025 is 28.5%, compared to 17.2% in 2024[34] - The company expects adjusted net income per diluted share for 2025 to be $2.87, reflecting leadership transition costs and gains on asset sales[36] Strategic Initiatives - The strategic transformation plan, called the Consumer First Formula, focuses on four key priorities to drive sustainable long-term growth[3]

Core Insights - The retailer has revised its profit forecast downward due to a decline in both sales and earnings [1] Group 1 - The company experienced a drop in sales, which has directly impacted its earnings [1] - As a result of the sales decline, the company has adjusted its profit outlook for the upcoming period [1]

Core Insights - Bath & Body Works, Inc. announced a comprehensive transformation plan called the Consumer First Formula aimed at revitalizing the brand and driving sustainable long-term growth [2][3] - The company reported third-quarter 2025 results with net sales of $1.594 billion, a decrease of 1% compared to the same quarter in 2024, and earnings per diluted share of $0.37, down from $0.49 [9][10] Strategic Transformation Plan - The Consumer First Formula focuses on four key priorities: creating disruptive and innovative products, reigniting the brand, winning in the marketplace, and operating with speed and efficiency [3] - The plan aims to attract younger consumers and unlock new growth opportunities [2] Financial Performance - Third-quarter net sales were $1,594 million, down from $1,610 million in the same quarter last year, representing a 1% decline [10][28] - Earnings per diluted share for the third quarter were $0.37, compared to $0.49 in the previous year [10][32] - Operating income decreased to $161 million from $218 million year-over-year [10][22] Guidance and Outlook - The company lowered its fourth-quarter 2025 net sales guidance to a decline in high single digits compared to $2,788 million in Q4 2024 [12] - Full-year 2025 net sales guidance was revised from a growth of 1.5% to 2.7% to a decline in low single digits compared to $7,307 million in fiscal 2024 [13] - The expected earnings per diluted share for full-year 2025 is now at least $2.83, down from $3.61 in fiscal 2024 [13] Cost Savings Initiatives - The company plans to deliver $250 million in cost savings over two years, with over half identified for 2026, to fund revenue-generating initiatives [7][9]

Bath & Body Works, Inc. (NYSE:BBWI) will release earnings results for the third quarter, before the opening bell on Thursday, Nov. 20.Analysts expect the Columbus, Ohio-based company to report quarterly earnings of 40 cents per share, down from 49 cents per share in the year-ago period. The consensus estimate for Bath & Body Works' quarterly revenue is $1.63 billion. Benzinga Pro data shows $1.61 billion in quarterly revenue a year ago.On Aug. 28, Bath & Body Works reported second-quarter fiscal 2025 net sa ...